Waddell & Reed Financial’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-48,620
Closed -$941K 521
2018
Q4
$941K Sell
48,620
-150,000
-76% -$3.29M ﹤0.01% 471
2018
Q3
$6.37M Sell
198,620
-1,380
-0.7% -$41.9K 0.01% 473
2018
Q2
$5.32M Buy
+200,000
New +$5.44M 0.01% 485

Other funds holding STIM

Waddell & Reed Financial's STIM Position: Q1 2019 in Review

Waddell & Reed Financial sold out of Neuronetics (STIM) in Q1 2019, closing a stake of 48,620 shares — an estimated $941K sold.

Waddell & Reed Financial first reported a position in STIM in Q2 2018 and held it in 3 quarters. The position peaked at $6.37M in Q3 2018. 66 funds tracked by Wall St. Rank hold STIM as of Q1 2019.

  • Waddell & Reed Financial reported no remaining Neuronetics position as of Q1 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 48,620 Neuronetics shares in Q1 2019, an estimated $941K.
  • Waddell & Reed Financial first reported a position in Neuronetics in Q2 2018 and held it in 3 quarters.
  • Waddell & Reed Financial's Neuronetics position peaked at $6.37M in Q3 2018.
  • 66 funds tracked by Wall St. Rank held Neuronetics as of Q1 2019.

Based on Waddell & Reed Financial's 13F filing for Q1 2019, filed 15 May 2019.